TCG and the Global Medical Diagnostics Industry

Successful diagnostics industry executives know that achieving a rapid time-to-market within the most cost-efficient pathway is an absolute requirement for being successful in today’s highly competitive global markets.  Likewise, because customer buying patterns can be entirely different in different countries, and even different regions within the same country, it takes a seasoned approach to identify the most promising opportunities in the global marketplace.  We work closely with you to sort through this complexity to develop strategies and tactics that produce superior results while minimizing the risk of implementation.    

To read sample Case Studies outlining the success stories of international diagnostic companies we have worked with, see below:

• International Market Opportunity Assessment for a Companion Diagnostic Product
• Value Proposition and Market Positioning for a Diagnostics Technology
• Commercial Pathway for an Innovative German Audiology Product
• Commercial Pathway for an Innovative Clinical Diagnostics Product

The US market is big and inviting, but there's a right way and a wrong way to jump in. Read more to avoid major mistakes.

Getting FDA approval is the first crucial step in bringing a product to market. But negotiating reimbursement with the payers should have the same priority. This TCG White paper discusses the Do’s and Don’ts.